Researcher.Life Logo

PAROLE RUBATE-RIVISTA INTERNAZIONALE DI STUDI SULLA CITAZIONE : Impact Factor & More

eISSN: 2039-0114pISSN: 2039-0114
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

PAROLE RUBATE-RIVISTA INTERNAZIONALE DI STUDI SULLA CITAZIONE Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
Overview
Publisher UNIV STUDI PARMA
Language Spanish,Italian,French,English
Frequency Semi-annual
Publication Time52
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageSpanish,Italian,French,English
Society/Institute/SponsorUniversity of Parma
FrequencySemi-annual
Publication Start Year2010
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 52
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in PAROLE RUBATE-RIVISTA INTERNAZIONALE DI STUDI SULLA CITAZIONE ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in PAROLE RUBATE-RIVISTA INTERNAZIONALE DI STUDI SULLA CITAZIONE

Evaluation of functional autonomy and neuropsychiatric symptoms in dementia and Mild Cognitive Impairment: a retrospective observational protocol.
  • 20 May 2026
  • Neurodegenerative disease management
Plain language summary: the evoke(+) studies of semaglutide for early Alzheimer's disease.
  • 20 May 2026
  • Neurodegenerative disease management
Beyond chronological age: biological aging and its relevance for motor and cognitive function in multiple sclerosis.
  • 19 May 2026
  • Neurodegenerative disease management
Alzheimer's disease and apitherapy: the therapeutic effect of various honeybee products.
  • 15 May 2026
  • Neurodegenerative disease management
Which medication improves fatigue in patients with multiple sclerosis (MS)?: a systematic review and network meta-analysis.
  • 14 May 2026
  • Neurodegenerative disease management
Perspectives in dementia risk reduction - food for thought.
  • 11 May 2026
  • Neurodegenerative disease management
Evaluation of functional autonomy and neuropsychiatric symptoms in dementia and Mild Cognitive Impairment: a retrospective observational protocol.
  • 20 May 2026
  • Neurodegenerative disease management
Plain language summary: the evoke(+) studies of semaglutide for early Alzheimer's disease.
  • 20 May 2026
  • Neurodegenerative disease management
Beyond chronological age: biological aging and its relevance for motor and cognitive function in multiple sclerosis.
  • 19 May 2026
  • Neurodegenerative disease management
Alzheimer's disease and apitherapy: the therapeutic effect of various honeybee products.
  • 15 May 2026
  • Neurodegenerative disease management
Which medication improves fatigue in patients with multiple sclerosis (MS)?: a systematic review and network meta-analysis.
  • 14 May 2026
  • Neurodegenerative disease management
Perspectives in dementia risk reduction - food for thought.
  • 11 May 2026
  • Neurodegenerative disease management

FAQs on PAROLE RUBATE-RIVISTA INTERNAZIONALE DI STUDI SULLA CITAZIONE